Postoperative agitation or postoperative delirium (EA/ED) has a high incidence among pediatric patients undergoing anesthesia and surgery. In this study, we aimed to evaluate the effects of sacral anesthesia with 0.125 mL/kg of 1% lidocaine on EA/ED in children undergoing hidden penis and hypospadias surgery. Sixty children aged 1–6 years undergoing elective hidden penis or hypospadias surgery were enrolled in the study. The postoperative EA/ED score and incidence; Face, Legs, Activity, Cry, and Consolability scale; perioperative general information and vital signs; and the occurrence of adverse events were analyzed. Ultrasound-guided sacral anesthesia in children resulted in more stable vital signs, postoperative pain relief, fewer complications, and lower incidence of EA/ED. In conclusion, the use of 0.125 mL/kg of 1% lidocaine combined with laryngeal mask general anesthesia significantly reduced the incidence of EA/ED in children undergoing hidden penis and hypospadias surgery while ensuring high perioperative safety.

The authors have declared no competing interest.

ChiCTR2200061552

Medical Education Research Project of Henan Province (WJLX2024007); Henan Province Medical Science and Technology Research Program Project (LHGJ20220068).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committee of Henan Provincial People's Hospital (No. 11,2022)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The raw data supporting the conclusions of this article will be made available by the authors on request